Studies have demonstrated that MK and PTN are involved in several types of carcinomas; the overexpression of MK or PTN correlated with a poor prognosis for patients with neuroblastomas, urinary bladder carcinomas, and papillary thyroid cancer (17–20). The gene discussed is MDK; the disease is carcinoma.